17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1.

Carrie L. Hayes, David C. Spink, Barbara C. Spink, +3

Proceedings of the National Academy of Sciences

Molecular PharmacologyE2 ConcentrationBeta-estradiol HydroxylationBiochemistryEndocrine Research +10

HIV Capsid is a Tractable Target for Small Molecule Therapeutic Intervention

Wade Blair, Chris Pickford, S.L. Irving, +16

PLoS Pathogens

ImmunologyMolecular BiologyAntiviral DrugMedicinal ChemistryHuman Retrovirus +17

An Integrated Genomic Approach to Identify Predictive Biomarkers of Response to the Aurora Kinase Inhibitor PF-03814735

Kenneth E. Hook, Scott J. Garza, Maruja E. Lira, +12

Molecular Cancer Therapeutics

Myc Gene FamilyEngineeringMolecular BiologyCancer BiologyTumor Biology +21

Induction of cytochrome P450 1B1 and catechol estrogen metabolism in ACHN human renal adenocarcinoma cells

David C. Spink, Barbara C. Spink, Joan Cao, +4

The Journal of Steroid Biochemistry and Molecular Biology

Toxicological MechanismOxidative StressNm TcddHepatotoxicityCytochrome P450 1B1 +14

Inductive and inhibitory effects of non-ortho-substituted polychlorinated biphenyls on estrogen metabolism and human cytochromes P450 1A1 and 1B1

Shaokun Pang, Joan Cao, Barbara H. Katz, +3

Biochemical Pharmacology

Endocrine DisruptorsEstrogen MetabolismInhibitory EffectsBiochemistryMedicine +7

New Small-Molecule Inhibitor Class Targeting Human Immunodeficiency Virus Type 1 Virion Maturation

Wade Blair, Joan Cao, Juin Fok‐Seang, +10

Antimicrobial Agents and Chemotherapy

Virion MaturationMedicineNatural SciencesHuman RetrovirusImmunology +13

Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancer

Shikhar Sharma, Chi‐Yeh Chung, Sean Uryu, +76

Cell chemical biology

Antitumor Efficacy of the Dual PI3K/mTOR Inhibitor PF-04691502 in a Human Xenograft Tumor Model Derived from Colorectal Cancer Stem Cells Harboring a PIK3CA Mutation

Douglas D. Fang, Cathy C. Zhang, Yin Gu, +17

PLoS ONE

Antitumor EfficacyCancer BiologyTumor BiologyOncologyPi3k/mtor Pathway +14

Combining CDK4/6 inhibition with taxanes enhances anti-tumor efficacy by sustained impairment of pRB-E2F pathways in squamous cell lung cancer

Joan Cao, Zhou Zhu, Hui Wang, +8

Oncogene

Prb-e2f PathwaysCdk4/6 InhibitionMedicineSustained ImpairmentBronchial Neoplasm +7

Multiplexed deep sequencing analysis of ALK kinase domain identifies resistance mutations in relapsed patients following crizotinib treatment

Donghui Huang, Dong‐Wan Kim, Αthanasios Kotsakis, +13

Genomics

MedicineReceptor Tyrosine KinaseCancer GenomicsCrizotinib TreatmentCancer Genetics +6